Two Sigma Investments LP Lowers Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

Two Sigma Investments LP trimmed its holdings in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 21.5% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 85,943 shares of the company's stock after selling 23,482 shares during the period. Two Sigma Investments LP owned approximately 0.10% of Pediatrix Medical Group worth $1,128,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Nomura Asset Management Co. Ltd. boosted its position in shares of Pediatrix Medical Group by 95.3% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock worth $33,000 after buying an additional 1,220 shares during the period. Parkside Financial Bank & Trust raised its stake in shares of Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock valued at $51,000 after acquiring an additional 1,040 shares in the last quarter. AlphaQuest LLC raised its stake in shares of Pediatrix Medical Group by 65.9% in the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock valued at $66,000 after acquiring an additional 2,012 shares in the last quarter. Smartleaf Asset Management LLC raised its stake in shares of Pediatrix Medical Group by 750.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock valued at $91,000 after acquiring an additional 6,090 shares in the last quarter. Finally, Tower Research Capital LLC TRC raised its stake in shares of Pediatrix Medical Group by 218.0% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock valued at $98,000 after acquiring an additional 5,104 shares in the last quarter. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Pediatrix Medical Group Price Performance

MD opened at $13.90 on Friday. The business's 50-day simple moving average is $13.66 and its 200-day simple moving average is $14.02. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60. Pediatrix Medical Group, Inc. has a one year low of $6.62 and a one year high of $17.67. The stock has a market capitalization of $1.19 billion, a P/E ratio of -11.58, a price-to-earnings-growth ratio of 1.74 and a beta of 1.26.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, topping analysts' consensus estimates of $0.25 by $0.08. The company had revenue of $458.36 million during the quarter, compared to analysts' expectations of $451.44 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The firm's revenue for the quarter was down 7.4% on a year-over-year basis. During the same period last year, the firm earned $0.20 EPS. Analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Analysts Set New Price Targets

Several analysts have recently issued reports on MD shares. Truist Financial reduced their price objective on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a research note on Friday, April 11th. Macquarie raised their price target on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research note on Thursday, May 8th. Finally, UBS Group cut their price target on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating on the stock in a research note on Monday, May 12th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, Pediatrix Medical Group has an average rating of "Hold" and a consensus price target of $16.67.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.